Pharmaceutical Fine Chemicals Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc.
“Pharmaceutical Fine Chemicals Market Worth $153.7 Billion By 2025�
The global pharmaceutical fine chemicals market is expected to reach USD 153.7 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for preventive healthcare is expected to be a major factor driving market growth. Utilization of pharmaceutical fine chemicals (PFCs) has increased on account of the increasing aging population across the globe. Cardiovascular is anticipated to the fastest growing application segment over the over the next eight years growing at an estimated CAGR of 8.4%. The occurrence of cardiovascular disease is on the rise owing to the unhealthy lifestyle of human beings. According to the World Health Organization (WHO), cardiovascular diseases are considered to be the prime cause of fatalities across the globe. The organization also states that cardiovascular diseases caused the death of approximately 17.7 million people in the year 2015. This number approximately represented 31% of the total deaths in the year 2015.
Obesity and an unhealthy lifestyle are some of the most important factors which lead to the occurrence of various diseases such as cardiovascular, neurological, oncological, infectious diseases, metabolic system, diabetes, respiratory, gastrointestinal, and musculoskeletal disorders. Eating junk food, leading unhygienic lifestyle, irregular timetable and many other unhealthy habits lead to diseases amongst human beings. Studies also show that males have more chance of contracting diabetes as compared to females. All these factors combined are thus anticipated to propel the market growth over the forecast period.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-finechemicals-market Further key findings from the report suggest:
Follow Us:
The global pharmaceutical fine chemicals demand in terms of revenue was USD 78.2 billion in 2016 and is expected to grow at a CAGR of 7.9% from 2017 to 2025
Proprietary emerged as the largest type segment in 2016 and is estimated to generate revenue of USD 125.1 billion by 2025
Big molecules were the largest size segment in 2016 and is expected to grow at an estimated CAGR of 7.8% over the next eight years
Advanced intermediates is expected to be the fastest growing product segment over the forecast period growing at an estimated CAGR of 8.3%
Industry participants include Angelini Acraf S.p.A, Albermarle Corporation, Chemada Fine Chemicals, W.R. Grace & Co., and Kenko Corporation. These players have vertically integrated their operations to increase their market presence and thus gain competitive advantage in the market
Grand View Research has segmented the global pharmaceutical fine chemicals market on the basis of application, type, size, product, and region: Pharmaceutical Fine Chemicals Application Outlook (Revenue, USD Billion, 2014 - 2025) Cardiovascular
Neurological
Oncological
Infectious diseases
Metabolic system
Diabetes
Respiratory
Gastrointestinal
Mucoskeletal
Others
Pharmaceutical Fine Chemicals Type Outlook (Revenue, USD Billion, 2014 - 2025) Proprietary
Non-proprietary
Pharmaceutical Fine Chemicals Size Outlook (Revenue, USD Billion, 2014 - 2025) Small molecules
Big molecules
Pharmaceutical Fine Chemicals Product Outlook (Revenue, USD Billion, 2014 - 2025) Basic building blocks
Advanced intermediates
Active ingredients
Pharmaceutical Fine Chemicals Regional Outlook (Revenue, USD Billion, 2014 - 2025)
Follow Us:
North America o
U.S.
Europe o
Germany
o
UK
Asia Pacific o
China
o
India
o
Japan
Central & South America
Middle East & Africa
Table of Content Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research scope and assumptions 1.3 List of data sources Chapter 2 Executive Summary 2.1 Pharmaceutical fine chemicals - Industry snapshot and key buying criteria Chapter 3 Pharmaceutical Fine Chemicals Market Variables, Trends and Scope 3.1 Market segmentation and scope 3.2 Penetration & growth prospect mapping 3.3 Value chain analysis 3.4 Market dynamics 3.5 Market driver analysis 3.5.1 Pharmaceutical fine chemicals – Key market driver impact 3.5.1.1 Increasing demand for preventive healthcare 3.5.1.2 Aging population 3.5.2 Pharmaceutical fine chemicals – Key market restraints impact 3.5.2.1 Overcapacity of manufacturing plants 3.6 Key opportunities prioritized
Follow Us:
3.7 Industry analysis - Porter’s 3.8 PESTEL analysis Continue………….. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market y provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and factbased research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:http://www.grandviewresearch.com
Follow Us: